Published recovery field note
IGF-1 LR3 1mg research compound with Batch B002 testing in progress. Prior Batch B001 Janoshik report retained for historical reference. For laboratory research use only.
Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.
IGF-1 LR3 1mg
Independent analytical testing is in progress. Sale is temporarily suspended until the final results are received and reviewed. Updated reports will be posted here once finalized.
Additional information
Additional information
0.94 oz
Single vial, 10-vial kit
Connected topics